7 items from 2013
You can’t say that Marvel doesn’t like to plan. Their mission to dominate our cinema screens and break box office records is showing no signs of stopping. The world which started back in 2008 with Iron Man, has gone on to make billions of dollars and ensure that Robert Downey Jr. has six yachts. With Ant-Man leading the charge for the third stage of Marvel’s Cinematic Universe, it turns out there’s more tricks up the studio’s sleeve.
With Iron Man 3 kicking off Phase Two of their cinematic universe with a resounding wallop and ka-ching! – the remaining projects have got some big clanky boots to fill. Next up is Thor: The Dark World, followed by Captain America: The Winter Soldier, Guardians Of The Galaxy and closing out the middle chapter is the glue that binds them together: The Avengers 2.
That brings us to Summer 2015. Where next, »
- Gem Seddon
It was nearly three years ago when we learned that Thomas Donnelly and Joshua Oppenheimer (Conan the Barbarian) had been hired to draft a screenplay for a live-action Doctor Strange feature film. The following summer they had reportedly turned in a draft for Marvel Studios to begin searching for a director to oversee the project’s development.
With the focus at the time being on Captain America: The First Avenger and Thor, both setting up for The Avengers the year after, Doctor Strange fell off the radar until recently when Marvel Studios President of Production Kevin Feige namedropped the neurosurgeon alongside Ant-Man as Phase Three films coming after The Avengers 2.
The untitled Avengers sequel marks the end of Phase Two in May 2015 but later that year, Edgar Wright’s Ant-Man launches Phase Three. Ant-Man is the only Phase Three movie (so far) with an official release date though ...
- Rob Keyes
Thomas Donnelly and Joshua Oppenheimer penned a script draft back in 2011, but no director is onboard yet. Theroux has had involvement with the Marvel Universe before - working on the script for the second "Iron Man" film. [Source: C.H.U.D.]
"Thor" villain Tom Hiddleston has confirmed he's scored the title role in Paul Andrew Williams' "Capa". The project isn't to be confused with the bigger budgeted "Waiting for Robert Capa" which Michael Mann is developing to direct.
A biopic on anti-fascist war photographer Robert Capa, the story will like focus on the romance he shared with fellow photographer Gerda Taro (to be played by Gemma Arterton). [Source: Shortlist]
Frank Langella has signed to play Harvey Molina, the fictional owner of the Cleveland Browns, in »
- Garth Franklin
So, what do we know about the long-rumored, long-developing "Doctor Strange" movie. Well, it has been confirmed as part of Marvel's Phase Three plans along with "Ant-Man," but that's about it. But if these latest rumors are to be believed (and as always take with a bit of a grain of salt), the comic studio may be starting to feel out leading men. According to sources speaking to Chud, actor/screenwriter Justin Theroux is being eyed for the part, though he could be one of a handful (or this could be completely erroneous). While it might seem mega early to cast the part, one wonders if they are looking to tease the character in an upcoming post-credits Marvel movie sequence or perhaps in the forthcoming "Agents Of S.H.I.E.L.D." At any rate, Theroux does have some history with the comics giant, having penned "Iron Man 2." Marvel »
- Kevin Jagernauth
Now comes word that Ant-Man will have company as part of Marvel’s future films following their Phase Two slate of Iron Man 3, Thor: The Dark World, Captain America: The Winter Soldier, and Guardians of the Galaxy.
Doctor Strange, which I’ve been talking about for years, is definitely one of them. … He’s a great, original character, and he checks the box off this criteria that I have: he’s totally different from anything else we have, just like Guardians of the Galaxy. He’s totally different from anything we’ve done before, as is Ant-Man, »
- Nick Martin
Roman Coppola, the son of famed director Franchis Ford Coppola revealed in a recent interview that twenty years ago he almost made a big screen adaptation of Doctor Strange for Marvel. While he was developing the film for Marvel their reputation was being shredded in a garbage disposal because of the terrible films that they were pumping out at the time. Roman ended up dropping out of the production because he didn't want to be tied down to the limitations of the studio system and it died. It's a shame, because the fact he wanted to make an accurate version of the story for the big screen could have been awesome. Here's what he had to say in the interview with MoviePilot,
You know, I did [have the desire to make a superhero movie], but I could again. I was a huge comic book fan growing up, within reason. I was a fan of Spider-Man and all that stuff. »
- Joey Paur
2011's Conan the Barbarian opened with a thud, only pulling in $16.6 million domestically in it's first ten days, and a paltry $5.5 million opening weekend overseas. The Lionsgate film cost around $70 million to produce and finished a few million shy of $50 million at the worldwide box office when it's run came to an end. The film was also panned by fans of Robert E. Howard's novels and Arnold Schwarzenegger's previous two Conan films. Critics were unkind to the film as well, it only garnered a 23% aggregate approval rating on Rotten Tomatoes. Who is to blame? Well, many will point their fingers at the screenwriters, but which one or two is deserves the scolding when their are four credited to the film? Screenwriters Thomas Dean Donnelly, Joshua Oppenheimer, Andrew Lobel, and Sean Hood all made contributions to the script. Perhaps this is why we haven't heard anything about Thomas »
7 items from 2013
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.See our NewsDesk partners